Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
March 1, 2016 - Constaffelsaal, Haus zum Rüden, Limmatquai 42, Zurich
February 8-9, 2016 - The Waldorf Astoria, New York City, USA
January 11-14, 2016 - the Westin St. Francis, San Francisco, US